Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Emilie

Showing results (161-170 of 166) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 166 results.
Journal of Hepatology|November 7, 1999
Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 GroupS Naveau, A Balian, F Degos, et al.
Gastroenterology|June 26, 1999
Inflammatory alterations in mesenteric adipose tissue in Crohn's diseaseP Desreumaux, O Ernst, K Geboes, et al.
Arthritis and Rheumatism|August 16, 2000
Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosusL Llorente, Y Richaud-Patin, C García-Padilla, et al.
AIDS (London, England)|August 16, 2001
Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) StudyD Emilie, M Burgard, C Lascoux-Combe, et al.
Arthritis and Rheumatism|July 1, 2009
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registryF Tubach, D Salmon, P Ravaud, et al.
Nature Medicine|December 1, 2001
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cellsW Zou, V Machelon, A Coulomb-L'Hermin, et al.
Pageof 17

Showing results (161-170 of 166) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 166 results.
Journal of Hepatology|November 7, 1999
Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 GroupS Naveau, A Balian, F Degos, et al.
Gastroenterology|June 26, 1999
Inflammatory alterations in mesenteric adipose tissue in Crohn's diseaseP Desreumaux, O Ernst, K Geboes, et al.
Arthritis and Rheumatism|August 16, 2000
Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosusL Llorente, Y Richaud-Patin, C García-Padilla, et al.
AIDS (London, England)|August 16, 2001
Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) StudyD Emilie, M Burgard, C Lascoux-Combe, et al.
Arthritis and Rheumatism|July 1, 2009
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registryF Tubach, D Salmon, P Ravaud, et al.
Nature Medicine|December 1, 2001
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cellsW Zou, V Machelon, A Coulomb-L'Hermin, et al.
Pageof 17